Campbell Soup Company is hoping to get its wining recipe from a new CEO. The packaged-food company announced Thursday that it has appointed Mark Clouse as president and CEO. Clouse has held executive positions at Pinnacle Foods (now owned by Conagra Brands) and Mondelez International.
Clouse will replace Campbell's interim CEO Keith McLoughlin, who had come in after Denise Morrison abruptly left her post as CEO in May.
Campbell Soup had been in a long-drawn battle this year with activist hedge fund Third Point, over the control of Campbell. In September, Third Point suggested replacing the entire board of Campbell. It later sued the company and accused Campbell of making boring, expensive soup. Campbell Soup shot back that Third Point’s opinions/ideas were uninformed.
Last month, Campbell and Third Point came to an agreement by increasing board from 12 to 14 members to include two out of five nominees recommended by Third Point. According to Bloomberg News, new CEO Clouse has long been the preferred choice of Third Point.
Amidst sluggish sales, Campbell Soup has been planning to sell some of its businesses such as its international line and Campbell Fresh. It wants to focus more on boosting revenues from its most popular brands. The company is probably expecting that Clouse, with his experience in packed-foods sector, would be able to bolster the turnaround strategies.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CPB saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 27, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 49 instances where the indicator turned negative. In 30 of the 49 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 61%.
The Momentum Indicator moved below the 0 level on September 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CPB as a result. In 44 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 49%.
CPB moved below its 50-day moving average on September 03, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CPB crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 54%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CPB's RSI Oscillator exited the oversold zone, 19 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 51%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where CPB advanced for three days, in 145 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.
CPB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 81 of 192 cases where CPB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 42%.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.627) is normal, around the industry mean (5.791). P/E Ratio (16.038) is within average values for comparable stocks, (35.005). Projected Growth (PEG Ratio) (0.542) is also within normal values, averaging (2.733). Dividend Yield (0.074) settles around the average of (0.059) among similar stocks. P/S Ratio (0.647) is also within normal values, averaging (4.670).
The Tickeron PE Growth Rating for this company is 46 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. CPB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CPB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of convenience food products, such as soups and sauces, pasta, broths, vegetable-beverages, cookies and biscuits
Industry FoodMajorDiversified